UnknownNot Applicable

Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors

United States54 participantsStarted 2006-01

Plain-language summary

RATIONALE: An exercise program or health education program may help relieve fatigue and pain and improve the quality of life in women who are breast cancer survivors. It is not yet known whether an exercise program is more effective than a health education program or no program in reducing fatigue and pain in women who are breast cancer survivors. PURPOSE: This randomized clinical trial is studying an exercise program to see how well it works in reducing fatigue and pain compared to a health education program or no program in women who are breast cancer survivors.

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Breast cancer survivor * Received adjuvant chemotherapy or radiotherapy for breast cancer only * Must have completed treatment 2-6 months ago * Hormone receptor status not specified PATIENT CHARACTERISTICS: * Female * Menopausal status not specified * Hemoglobin ≥ 11 g/dL * Able to read English * No high-risk for cardiovascular problems during exercise, including any of the following: * Unstable heart disease * Unstable angina * Chronic respiratory disease * Dizziness * Uncontrolled hypertension * No severe respiratory disease requiring oxygen therapy * No history of anorexia (body mass index \[BMI\] \< 18.5) or severe obesity (BMI \> 35) * No history of multiple cancers * No shortness of breath or hypotension * No sudden swelling of the ankles, hands or face * No palpitations or arrhythmias * No persistent and intolerable pain * No major acute illness (e.g., fever or respiratory infection) PRIOR CONCURRENT THERAPY: * See Disease Characteristics

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

Trial details

NCT IDNCT00336089

SponsorClayton State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-12

View on ClinicalTrials.gov More Breast Cancer trials